Publikationen, an denen er mitarbeitet José María López-Picazo González (29)

2022

  1. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

    Cancer Letters, Vol. 529, pp. 70-84

  2. DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity

    The Journal of experimental medicine, Vol. 219, Núm. 12

2020

  1. Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade

    Nature cancer, Vol. 1, Núm. 1, pp. 75-85

2018

  1. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

2017

  1. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche

    Cancer Letters, Vol. 402, pp. 43-51

2014

  1. Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

    Journal of Translational Medicine, Vol. 11, Núm. 1

2012

  1. The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience

    Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841

2010

  1. Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo

    Molecular Cancer, Vol. 9

  2. Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer

    BMC Genomics, Vol. 11, Núm. 1

  3. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression

    Clinical Cancer Research, Vol. 16, Núm. 16, pp. 4113-4125

2009

  1. EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration

    European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486

  2. Role of surgery in a multidisciplinary approach to superior sulcus tumors (SST): Morbidity and prognostic factors for long-term success after resection

    Thoracic and Cardiovascular Surgeon, Vol. 57, Núm. 6, pp. 353-357

2008

  1. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation

    Radiotherapy and Oncology, Vol. 88, Núm. 3, pp. 342-350

2007

  1. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 9, pp. 596-602

2005

  1. Initial results of a prospective clinical study of cisplatin/paclitaxelbased hyperfiractionated chemoradiation (3DCRTHF) in squamous cell head and neck cancer (HNC) stages III-IV

    EJC SUPPLEMENTS

  2. Radiation pneumonitis following combined modality therapy in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC) including three-dimensional conformal radiation therapy (3D-CRT):: analysis of clinical and dosimetric prognostic factors

    EJC SUPPLEMENTS

  3. Three-dimensional conformal radiation therapy (3D-CRT) in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC):: Influence of clinical and dosimetric parameters on patterns of failure and survival

    EJC SUPPLEMENTS

  4. Three-dimensional conformal radiation therapy (3D-CRT) in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC):: Influence of clinical and dosimetric parameters on patterns of failure and survival

    EJC SUPPLEMENTS

2004

  1. Does it worth to avoid pneumonectomy in surgery for lung cancer in the "era of multidisciplinary treatment"?

    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE